Search for stocks /

Max India Ltd Q2 FY26 – The ₹158 Cr Senior Care Saga with 82% Sold-out Towers, ₹145 Cr Losses & a ₹124 Cr Rights Issue Reality Check


1. At a Glance

Max India Ltd (NSE: MAXIND, BSE: 543223) – the flagbearer of Antara Senior Care, the Max Group’s ambitious social-meets-silver-economy experiment – currently trades around ₹195, giving it a market cap of roughly ₹1,014 crore. The company’s FY25 numbers, however, tell a very non-retirement-friendly story: Sales ₹158 crore, PAT ₹–145 crore, and Operating Profit Margin a jaw-dropping –81.8%.

Quarterly results don’t soothe nerves either – the Q2 FY26 (Sept 2025) quarter saw Sales ₹45 crore, PAT ₹–34 crore, and an EPS of –₹6.52. That’s not senior-care – that’s investor-care required. The book value sits at ₹89.4, while ROCE and ROE both bleed at –23.6% and –30% respectively. Debt has risen to ₹204 crore (Debt/Equity 0.44x), and yet, the company went ahead with a ₹124.23 crore rights issue in FY25 to fuel its expansion spree.

The stock has slipped –12.8% in a year, but delivered a 28% CAGR over five years, mainly on hype rather than hard cash. With promoters holding 49.6% and institutions quietly trimming stakes, the question writes itself: Can Max India finally make old age profitable – or is it the company itself that’s ageing badly?


2. Introduction

Once upon a time, Max India was part of the healthcare-insurance juggernaut — a respectable elder sibling in the Max family. Then came a corporate restructuring that left this version of Max India as the custodian of old age. Literally.

Today’s Max India runs Antara Senior Care, a business promising peaceful, premium, Instagram-ready retirements for India’s growing elderly population. Think of it as a gated community for your post-pension years — complete with physiotherapy, memory care homes, and a ₹20 lakh per bed business model that tries to monetise loneliness and declining mobility with spa-like precision.

But beneath the empathy, there’s arithmetic. FY25 saw revenues of ₹158 crore and losses of ₹145 crore, even as Antara’s Gurgaon towers sold 82% of their flats. This isn’t exactly the “retirement dividend” analysts dream of.

Still, there’s no denying the ambition. The company wants to add 1.5 million sq. ft. of new projects annually, open care homes across Chennai, Bengaluru, Noida, and Chandigarh, and expand its AGEasy product line to offline retail. It’s a play on India’s demographic shift — but with financials that look more like a start-up’s burn rate than a mature holding company’s report card.


3. Business Model – WTF Do They Even Do?

Max India is no longer a sprawling conglomerate. It’s a focused bet on senior care, operating primarily through its flagship Antara brand and subsidiaries such as Max Estates Gurgaon Ltd (MEGL). Let’s decode this geriatric jigsaw puzzle.

  1. Senior Living Residences
    The jewel in the crown. Antara launched intergenerational living towers in Gurugram — posh, community-centric apartments that promise “vibrant retirement living”. With 82% of units sold (240 of 292) and Phase-2 projects planned for Gurgaon and Chandigarh, this vertical is all about real estate with empathy. Antara earns both sales margins and resale management fees here.
  2. Assisted Care Services
    These are operational businesses: care homes, memory care centres, and at-home nursing/physio services. Current capacity stands around 300 beds (Gurugram 160, Bengaluru 83, Noida 53), with another 250 beds on the way across Chennai and Bengaluru. The company’s model is asset-light — leased properties at ~₹10 lakh per bed. Q3 FY25 saw revenue of ₹2.1 crore, up 40% YoY and 22% QoQ, but nowhere near scale profitability.
  3. AGEasy Products
    The e-commerce baby of the group. AGEasy sells 60+ products across 180 SKUs — from commode frames to foot insoles — through Amazon (68%), D2C (22%), and offline stores (10%). Q3 FY25 clocked ₹12.7 crore in revenue, up 92% over Q2. Cute growth — but hardly a cash cow yet.

In short: Max India builds luxury homes for the old, rents care beds for the frail, and sells mobility aids for the rest. A noble cause packaged in private-equity chic. The only problem? The profits are still missing in action.


4. Financials Overview

Metric (₹ Cr)Q2 FY26 (Latest)Q2 FY25 (YoY)Q1 FY26 (QoQ)YoY %QoQ %
Revenue45.242.737.0+5.9%+22.2%
EBITDA-31-41-28–24.4%–10.7%
PAT-34-46-26+26.1%–30.8%
EPS (₹)
Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!